Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 11Observational 1

Sponsor

Cancer Type

Thoracic 1Head & Neck 1Genitourinary 1Gastrointestinal 1CNS 1Breast 1

Conditions

Breast Neoplasms 21Head and Neck Neoplasms 17Prostatic Neoplasms 15Neoplasms 12Lung Neoplasms 12Radiation Injuries 9Esophageal Neoplasms 8Rectal Neoplasms 7Glioma 7Brain Neoplasms 7Glioblastoma 6Carcinoma, Non-Small-Cell Lung 6Uterine Cervical Neoplasms 5Squamous Cell Carcinoma of Head and Neck 5Neoplasm Metastasis 5Carcinoma, Hepatocellular 4Stomach Neoplasms 3Colorectal Neoplasms 3Central Nervous System Neoplasms 3Astrocytoma 3Xerostomia 2Urinary Bladder Neoplasms 2Small Cell Lung Carcinoma 2Sarcoma 2Salivary Gland Neoplasms 2Pelvic Neoplasms 2Osteoradionecrosis 2Lymphedema 2Kidney Neoplasms 2Esthesioneuroblastoma, Olfactory 2

Interventions

Hepatectomy 10Blood Specimen Collection 9Sorafenib 7Polymerase Chain Reaction 4Biopsy 4regorafenib 3Mass Spectrometry 3Liver Transplantation 3Immunohistochemistry 3Chemoembolization, Therapeutic 3Walking Speed 2Surveys and Questionnaires 2Psychiatric Rehabilitation 2Magnetic Resonance Imaging 2Gene Expression Profiling 2Bevacizumab 2trastuzumab deruxtecan 1taxane 1spartalizumab 1sintilimab 1lenvatinib 1gadolinium ethoxybenzyl DTPA 1donafenib 1carmofur 1camrelizumab 1cabozantinib 1atezolizumab 1apatinib 1anlotinib 1Yttrium-90 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Liver Neoplasms × Radiotherapy × Clear all
NCT04075305 2026-03-05

MOMENTUM

UMC Utrecht

Recruiting
8,000 enrolled
BreastCNSGastrointestinalGenitourinaryHead & NeckThoracic

Urinary Bladder Neoplasms, Brain Neoplasms, Breast Neoplasms, Esophageal Neoplasms, Genital Neoplasms, Female, Head and Neck Neoplasms, Liver Neoplasms, Lung Neoplasms, Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Radiation Injuries, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡